The catalyst of decentralized clinical trials: combining clinical and digital

23rd Jun 2022

Decentralized clinical trials are made up of a multitude of elements, from in home clinical capabilities, logistics, digital platforms, and technology, to global reach and more. Putting these elements together and getting them to work in a carefully managed and coordinated way is complex.

MRN have over 16 years of experience designing and executing custom decentralized clinical trial ‘molecules’ for our customers protocol and patient needs; in this session Todd McGrath, our Senior Vice President of Portfolio Delivery will share important factors to consider to build your DCT ‘molecule’ successfully.

Back to the resources